Health effects of arsenic and chromium in drinking water: Recent human findings

Annual Review of Public Health

Volumn 30, Issue , 2009, Pages 107-122

  Smith, Allan H ^a   Steinmaus, Craig M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Childhood cancer; Early life exposure; Methylation; Skin lesions

Indexed keywords

ARSENIC; CHROMIUM; DRINKING WATER; WELL WATER;

ACUTE HEART INFARCTION; ADULT DISEASE; BRONCHIECTASIS; CANCER MORTALITY; CANCER RISK; CARCINOGENESIS; CARDIOVASCULAR DISEASE; CHILDHOOD CANCER; CHINA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COGNITIVE DEFECT; ENVIRONMENTAL EXPOSURE; FETUS WASTAGE; HUMAN; INFANT MORTALITY; LOW BIRTH WEIGHT; METHYLATION; MORTALITY; PREGNANCY OUTCOME; PRENATAL EXPOSURE; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SKIN DEFECT; SPONTANEOUS ABORTION; STILLBIRTH; STOMACH CANCER; VASCULAR DISEASE; WATER CONTAMINATION;

ARSENIC; CHROMIUM; CHRONIC DISEASE; DRINKING; ENVIRONMENTAL EXPOSURE; FEMALE; HUMANS; MALE; METHYLATION; PREGNANCY; PREGNANCY OUTCOME; SKIN NEOPLASMS; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 67650753855     PISSN: 01637525     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.publhealth.031308.100143     Document Type: Review

References (91)

1. Ahmad SA, Khatun F, Sayed MH, Khan MH, Aziz R, et al. 2006. Electrocardiographic abnormalities among arsenic-exposed persons through groundwater in Bangladesh. J. Health Popul. Nutr. 24:221-27
2. Ahmad SA, Sayed MH, Barua S, Khan MH, Faruquee MH, et al. 2001. Arsenic in drinking water and pregnancy outcomes. Environ. Health Perspect. 109:629-31
3. Ahsan H, Chen Y, Kibriya MG, Slavkovich V, Parvez F, et al. 2007. Arsenic metabolism, genetic susceptibility, and risk of premalignant skin lesions in Bangladesh. Cancer Epidemiol. Biomarkers Prev. 16:1270-78
4. Ahsan H, Chen Y, Parvez F, Zablotska L, Argos M, et al. 2006. Arsenic exposure from drinking water and risk of premalignant skin lesions in Bangladesh: baseline results from the Health Effects of Arsenic Longitudinal Study. Am. J. Epidemiol. 163:1138-48
5. Ahsan H, Perrin M, Rahman A, Parvez F, Stute M, et al. 2000. Associations between drinking water and urinary arsenic levels and skin lesions in Bangladesh. J. Occup. Environ. Med. 42:1195-201
6. Beaumont JJ, Sedman RM, Reynolds SD, Sherman CD, Li LH, et al. 2008. Cancer mortality in a Chinese population exposed to hexavalent chromium in drinking water. Epidemiology 19:12-23
7. Borzsonyi M, Bereczky A, Rudnai P, Csanady M, Horvath A. 1992. Epidemiological studies on human subjects exposed to arsenic in drinking water in southeast Hungary. Arch. Toxicol. 66:77-78
8. Brandt-Rauf P. 2006. Editorial retraction. Cancer mortality in a Chinese population exposed to hexavalent chromium in water. J. Occup. Environ. Med. 48:749
9. Buchet JP, Lauwerys R, Roels H. 1981. Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48:71-79
10. Chakraborty AK, Saha KC. 1987. Arsenical dermatosis from tubewell water in West Bengal. Indian J. Med. Res. 85:326-34
11. Chen Y, Factor-Litvak P, Howe GR, Graziano JH, Brandt-Rauf P, et al. 2007. Arsenic exposure from drinking water, dietary intakes of B vitamins and folate, and risk of high blood pressure in Bangladesh: a population-based, cross-sectional study. Am. J. Epidemiol. 165:541-52
12. Chen Y, Hakim ME, Parvez F, Islam T, Rahman AM, Ahsan H. 2006. Arsenic exposure from drinking-water and carotid artery intima-medial thickness in healthy young adults in Bangladesh. J. Health Popul. Nutr. 24:253-57
13. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith TJ, et al. 2003. Arsenic methylation and skin cancer risk in southwestern Taiwan. J. Occup. Environ. Med. 45:241-28
14. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, et al. 2003. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14:303-10
15. Chiu HF, Lin MC, Yang CY. 2007. Primary intracerebral hemorrhage mortality reduction after installation of a tap-water supply system in an arseniasis-endemic area in southwestern Taiwan. J. Toxicol. Environ. Health A 70:539-46
16. Christian WJ,Hopenhayn C, Centeno JA, Todorov T. 2006. Distribution of urinary selenium and arsenic among pregnant women exposed to arsenic in drinking water. Environ. Res. 100:115-22
17. Concha G,Vogler G, Nermell B,Vahter M. 2002. Intra-individual variation in the metabolism of inorganic arsenic. Int. Arch. Occup. Environ. Health 75:576-80
18. Cullen W, Reimer K. 1989. Arsenic speciation in the environment. Chem. Rev. 89:713-64
19. Egilman D, Scout. 2006. Corporate corruption of science - the case of chromium(VI). Int. J. Occup. Environ. Health 12:169-76
20. Engel RR, Hopenhayn-Rich C, Receveur O, Smith AH. 1994.Vascular effects of chronic arsenic exposure: a review. Epidemiol. Rev. 16:184-209
21. Enterline PE, Henderson VL, Marsh GM. 1987. Exposure to arsenic and respiratory cancer. A reanalysis. Am. J. Epidemiol. 125:929-38
22. Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, et al. 2007. Folic acid supplementation lowers blood arsenic. Am. J. Clin. Nutr. 86:1202-9
23. Gebel TW. 2002. Arsenic methylation is a process of detoxification through accelerated excretion. Int. J. Hyg. Environ. Health 205:505-8
24. Ghosh P, Banerjee M, De Chaudhuri S, Chowdhury R, Das JK, et al. 2007. Comparison of health effects between individuals with and without skin lesions in the population exposed to arsenic through drinking water inWest Bengal, India. J. Expo. Sci. Environ. Epidemiol. 17:215-23
25. Guha Mazumder DN, Haque R, Ghosh N, De BK, Santra A, et al. 1998. Arsenic levels in drinking water and the prevalence of skin lesions inWest Bengal, India. Int. J. Epidemiol. 27:871-77
26. Haque R, Mazumder DN, Samanta S, Ghosh N, Kalman D, et al. 2003. Arsenic in drinking water and skin lesions: dose-response data fromWest Bengal, India. Epidemiology 14:174-82
27. Heck JE, Chen Y, Grann VR, Slavkovich V, Parvez F, Ahsan H. 2008. Arsenic exposure and anemia in Bangladesh: a population-based study. J. Occup. Environ. Med. 50:80-87
28. Hopenhayn C, Ferreccio C, Browning SR, Huang B, Peralta C, et al. 2003. Arsenic exposure from drinking water and birth weight. Epidemiology 14:593-602
29. Hopenhayn-Rich C, Browning SR, Hertz-Picciotto I, Ferreccio C, Peralta C, Gibb H. 2000. Chronic arsenic exposure and risk of infant mortality in two areas of Chile. Environ. Health Perspect. 108:667-73
30. Hopenhayn-Rich C, Smith AH, Goeden HM. 1993. Human studies do not support the methylation threshold hypothesis for the toxicity of inorganic arsenic. Environ. Res. 60:161-77
31. Hsueh YM, Chiou HY, Huang YL,Wu WL, Huang CC, et al. 1997. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer. Cancer Epidemiol. Biomarkers Prev. 6:589-96
32. Huang YK Huang YL, Hsueh YM, Yang MH, Wu MM, et al. 2008. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study. Cancer Causes Control 19:829-39
33. Huang YK, Tseng CH,Huang YL, Yang MH, Chen CJ, Hsueh YM. 2007. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan. Toxicol. Appl. Pharmacol. 218:135-42
34. Huyck KL, Kile ML,Mahiuddin G, Quamruzzaman Q, Rahman M, et al. 2007. Maternal arsenic exposure associated with low birth weight in Bangladesh. J. Occup. Environ. Med. 49:1097-104
35. Infante-Rivard C, Olson E, Jacques L, Ayotte P. 2001. Drinking water contaminants and childhood leukemia. Epidemiology 12:13-19
36. Int. Agency Res. Cancer (IARC). 1990. Chromium and chromium compounds. In IARC Monographs on the Evaluation of Carcinogenic Risks to Humans: Chromium, Nickel, and Welding. Lyon: IARC
37. Kwok RK, Kaufmann RB, Jakariya M. 2006. Arsenic in drinking-water and reproductive health outcomes: a study of participants in the Bangladesh Integrated Nutrition Programme. J. Health Popul. Nutr. 24:190-205
38. Kwok RK, Mendola P, Liu ZY, Savitz DA, Heiss G, et al. 2007. Drinking water arsenic exposure and blood pressure in healthy women of reproductive age in Inner Mongolia, China. Toxicol. Appl. Pharmacol. 222:337-43
39. Lee-Feldstein A. 1986. Cumulative exposure to arsenic and its relationship to respiratory cancer among copper smelter employees. J. Occup. Med. 28:296-302
40. Liaw J, Marshall G, Yuan Y, Ferreccio C, Steinmaus C, Smith AH. 2008. Increased childhood liver cancer mortality and arsenic in drinking water in Northern Chile. Cancer Epidemiol. Biomarkers Prev. 17:1982-87
41. Lindberg AL, Rahman M, Persson LA, Vahter M. 2008. The risk of arsenic induced skin lesions in Bangladeshi men and women is affected by arsenic metabolism and the age at first exposure. Toxicol. Appl. Pharmacol. 1:9-16
42. Maharjan M, Watanabe C, Ahmad SA, Ohtsuka R. 2005. Arsenic contamination in drinking water and skin manifestations in lowland Nepal: the first community-based survey. Am. J. Trop. Med. Hyg. 73:477-79
43. Maki-Paakkanen J, Kurttio P, Paldy A, Pekkanen J. 1998. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ. Mol. Mutagen. 32:301-13
44. Marafante E, Vahter M. 1984. The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. Chem. Biol. Interact. 50:49-57
45. Marafante E, Vahter M, Envall J. 1985. The role of the methylation in the detoxication of arsenate in the rabbit. Chem. Biol. Interact. 56:225-38
46. Marshall G, Ferreccio C, Yuan Y, Bates M, Steinmaus C, et al. 2007. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J. Natl. Cancer Inst. 99:920-28
47. Mass MJ, Tennant A, Roop BC, Cullen WR, Styblo M, et al. 2001. Methylated trivalent arsenic species are genotoxic. Chem. Res. Toxicol. 14:355-61
48. McCarty KM, Chen YC, Quamruzzaman Q, Rahman M, Mahiuddin G, et al. 2007. Arsenic methylation, GSTT1, GSTM1, GSTP1 polymorphisms, and skin lesions. Environ. Health Perspect. 115:341-45
49. McDonald C, Hoque R, Huda N, Cherry N. 2007. Risk of arsenic-related skin lesions in Bangladeshi villages at relatively low exposure: a report from Gonoshasthaya Kendra. Bull.World Health Organ. 85:668-73
50. Meliker JR, Wahl RL, Cameron LL, Nriagu JO. 2007. Arsenic in drinking water and cerebrovascular disease, diabetes mellitus, and kidney disease in Michigan: a standardized mortality ratio analysis. Environ. Health 6:4
51. Milton AH, Smith WP, Rahman B, Hasan Z, Kulsum Z, et al. 2005. Chronic arsenic exposure and adverse pregnancy outcomes in Bangladesh. Epidemiology 16:82-86
52. Moore LE, Lu ML, Smith AH. 2002. Childhood cancer incidence and arsenic exposure in drinking water in Nevada. Arch. Environ. Health 57:201-6
53. Moore MM, Harrington-Brock K, Doerr CL. 1997. Relative genotoxic potency of arsenic and its methylated metabolites. Mutat. Res. 386:279-90
54. Mumford JL,Wu K, Xia Y, Kwok R, Yang Z, et al. 2007. Chronic arsenic exposure and cardiac repolarization abnormalities with QT interval prolongation in a population-based study. Environ. Health Perspect. 115:690-94
55. Natl. Toxicol. Progr. Dep. Health Hum. Serv. 2007. Toxicology and carcinogenesis studies of dodium dichromate dihydrate (CAS No. 7789-12-0) in F344/N rats and B6C3F1 mice (drinking water studies). Rep. NTP: TR-546, Research Triangle Park, NC
56. Natl. Res. Counc. (NRC). 1999. Arsenic in Drinking Water. Washington, DC: Natl. Acad. Press. xvii, 310 pp.
57. Navas-Acien A, Sharrett AR, Silbergeld EK, Schwartz BS, Nachman KE, et al. 2005. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am. J. Epidemiol. 162:1037-49
58. Petrick JS, Ayala-Fierro F, Cullen WR, Carter DE, Vasken Aposhian H. 2000. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes. Toxicol. Appl. Pharmacol. 163:203-7
59. Pu YS, Yang SM, Huang YK, Chung CJ, Huang SK, et al. 2007. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure. Toxicol. Appl. Pharmacol. 218:99-106
60. Rahman A, Vahter M, Ekstrom EC, Rahman M, Golam Mustafa AH, et al. 2007. Association of arsenic exposure during pregnancy with fetal loss and infant death: a cohort study in Bangladesh. Am. J. Epidemiol. 165:1389-96
61. Rahman M, Vahter M, Sohel N, Yunus M, Wahed MA, et al. 2006. Arsenic exposure and age and sex-specific risk for skin lesions: a population-based case-referent study in Bangladesh. Environ. Health Perspect. 114:1847-52
62. Rahman M, Vahter M, Wahed MA, Sohel N, Yunus M, et al. 2006. Prevalence of arsenic exposure and skin lesions. A population based survey in Matlab, Bangladesh. J. Epidemiol. Community Health 60:242-48
63. Siripitayakunkit U, Lue S, Choprapawon C. 2001. Possible effects of arsenic on visual perception and visual-motor integration of children in Thailand. In Arsenic Exposure and Health Effects IV, ed. WR Chappell, CO Abernathy, RL Calderon, pp. 165-72. New York: Elsevier
64. Smith AH. 2008. Hexavalent chromium, yellow water, and cancer: a convoluted saga. Epidemiology 19:24-26
65. Smith AH, Goycolea M, Haque R, Biggs ML. 1998. Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147:660-69
66. Smith AH,Marshall G, Yuan Y, Ferreccio C, Liaw J, et al. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ. Health Perspect. 114:1293-96
67. -/- mice. Reprod. Toxicol. 23:449-56
68. Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, et al. 2006. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J. Occup. Environ. Med. 48:478-88
69. Steinmaus C, Moore LE, Shipp M, Kalman D, Rey OA, et al. 2007. Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic. J. Toxicol. Environ. Health A 70:159-70
70. Steinmaus C, Yuan Y, Kalman D, Atallah R, Smith AH. 2005. Intraindividual variability in arsenic methylation in a U.S. population. Cancer Epidemiol. Biomarkers Prev. 14:919-24
71. StybloM,Del RazoLM,Vega L, Germolec DR, LeCluyse EL, et al. 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74:289-99
72. Tondel M, Rahman M, Magnuson A, Chowdhury IA, Faruquee MH, Ahmad SA. 1999. The relationship of arsenic levels in drinking water and the prevalence rate of skin lesions in Bangladesh. Environ. Health Perspect. 107:727-29
73. Tsai SY, Chou HY, The HW, Chen CM, Chen CJ. 2003. The effects of chronic arsenic exposure from drinking water on the neurobehavioral development in adolescence. Neurotoxicology 24:747-53
74. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, et al. 2005. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol. Appl. Pharmacol. 206:299-308
75. Tseng WP, Chu HM, How SW, Fong JM, Lin CS, Yeh SJ. 1968. Prevalence of skin cancer in an endemic area of chronic arsenicism in Taiwan. J. Natl. Cancer Inst. 40:453-63
76. Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181-182:211-7
77. Vahter M. 2008. Health effects of early life exposure to arsenic. Basic Clin. Pharmacol. Toxicol. 102:204-11
78. Valenzuela OL, Borja-Aburto VH, Garcia-Vargas GG, Cruz-Gonzalez MB, Garcia-Montalvo EA, et al. 2005. Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic. Environ. Health Perspect. 113:250-54
79. von Ehrenstein OS, Guha Mazumder DN, Hira-Smith M, Ghosh N, Yuan Y, et al. 2006. Pregnancy outcomes, infant mortality, and arsenic in drinking water inWest Bengal, India. Am. J. Epidemiol. 163:662-69
80. von Ehrenstein OS, Poddar S, Yuan Y, Mazumder DG, Eskenazi B, et al. 2007. Children's intellectual function in relation to arsenic exposure. Epidemiology 18:44-51
81. Waalkes MP, Keefer LK, Diwan BA. 2000. Induction of proliferative lesions of the uterus, testes, and liver in Swiss mice given repeated injections of sodium arsenate: possible estrogenic mode of action. Toxicol. Appl. Pharmacol. 166:24-35
82. Waalkes MP, Liu J, Diwan BA. 2007. Transplacental arsenic carcinogenesis in mice. Toxicol. Appl. Pharmacol. 222:271-80
83. WangCH,Hsiao CK, Chen CL, Hsu LI, Chiou HY, et al. 2007.Areview of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol. Appl. Pharmacol. 222:315-26
84. Wasserman GA, Liu X, Parvez F, Ahsan H, Factor-Litvak P, et al. 2004. Water arsenic exposure and children's intellectual function in Araihazar, Bangladesh. Environ. Health Perspect. 112:1329-33
85. Wilcox AJ, Savitz DA, Samet JM. 2008. A tale of two toxicants: lessons from Minamata and Liaoning. Epidemiology 19:1-2
86. Wu MM, Chiou HY, Hsueh YM, Hong CT, Su CL, et al. 2006. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Toxicol. Appl. Pharmacol. 216:168-75
87. Yang CY, Chang CC, Tsai SS, Chuang HY,Ho CK,Wu TN. 2003. Arsenic in drinking water and adverse pregnancy outcome in an arseniasis-endemic area in northeastern Taiwan. Environ. Res. 91:29-34
88. Yu RC, Hsu KH, Chen CJ, Froines JR. 2000. Arsenic methylation capacity and skin cancer. Cancer Epidemiol. Biomarkers Prev. 9:1259-62
89. Yuan Y, Marshall G, Ferreccio C, Steinmaus C, Selvin S, et al. 2007. Acute myocardial infarction mortality in comparison with lung and bladder cancer mortality in arsenic-exposed region II of Chile from 1950 to 2000. Am. J. Epidemiol. 166:1381-91
90. Zhang JD, Li S. 1997. Cancer mortality in a Chinese population exposed to hexavalent chromium in water. J. Occup. Environ. Med. 39:315-19
91. Zhang JD, Li XL. 1987. Chromium pollution of soil and water in Jinzhou. Zhonghua Yu Fang Yi Xue Za Zhi 21:262-64